EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, Synthesis, and Biological Evaluation of Novel Multitarget 7-Alcoxyamino-3-(1,2,3-triazole)-coumarins as Potent Acetylcholinesterase Inhibitors

Nathalia F Nadur iD, Larissa de A P Ferreira, Daiana P Franco, Luciana L de Azevedo, Lucas Caruso iD, Thiago da S Honório iD, Priscila de S Furtado, Alice Simon iD, Lucio M Cabral, Tobias Werner iD, Holger Stark iD, Arthur E Kümmerle iD

Pharmaceuticals · 17.09.2025 · 18 (9) · 1398

DOI: 10.3390/ph18091398 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 17.09.2025. Verfasst von Nathalia F Nadur und 11 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Diversity and Medicinal Chemistry (LaDMol-QM), Graduate Program in Chemistry (PPGQ), Institute of Chemistry, Federal Rural Un…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Coordenação de Aperfeicoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Multitarget-directed ligands (MTDLs), particularly those combining cholinesterase inhibition with additional mechanisms, are promising candidates for Alzheimer’s disease (AD) therapy. Based on our previous identification of a dual-active coumarin derivative, we designed a new series of 7-alkoxyamino-3-(1,2,3-triazole)-coumarins.

Methods

These compounds were synthesized by a new Sonogashira protocol and evaluated for AChE and BChE inhibition, enzymatic kinetics, molecular docking, neurotoxicity in SH-SY5Y cells, neuroprotection against H2O2-induced oxidative stress, and additional interactions with H3R and MAOs.

Results

All derivatives inhibited AChE with IC50 values of 4–104 nM, displaying high selectivity over BChE (up to 686-fold). Kinetic and docking studies indicated mixed-type inhibition involving both CAS and PAS. The most potent compounds (1h, 1j, 1k, 1q) were non-neurotoxic up to 50 µM, while 1h and 1k also showed neuroprotective effects at 12.5 µM. Selected derivatives (1b, 1h, 1q) demonstrated multitarget potential, including H3R affinity (Ki as low as 32 nM for 1b) and MAO inhibition (IC50 of 1688 nM for 1q).

Conclusions

This series of coumarin–triazole derivatives combines potent and selective AChE inhibition with neuroprotective and multitarget activities, highlighting their promise as candidates for AD therapy.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer diseaseH3R ligandscholinesterase inhibitorsclick chemistrymultitarget-directed ligands

Autor:innen und Institutionen

  • Laboratory of Molecular Diversity and Medicinal Chemistry (LaDMol-QM), Graduate Program in Chemistry (PPGQ), Institute of Chemistry, Federal Rural University of Rio de Janeiro, Rio de Janeiro 23897-000, Brazil.
  • Cell Culture Laboratory (LabCel), Department of Drugs and Pharmaceutics, Faculty of Pharmacy, Federal Rural University of Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
  • Institute of Pharmaceutical and Medicinal Chemistry, Heinrich Heine University Düsseldorf, 40225 Duesseldorf, Germany.

ORCID-Profile: Nathalia F Nadur, Lucas Caruso, Thiago da S Honório, Alice Simon, Tobias Werner, Holger Stark, Arthur E Kümmerle

Förderung

  • National Council for Scientific and Technological Development
  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
  • Coordenação de Aperfeicoamento de Pessoal de Nível Superior
  • Fundação de Amparo a Pesquisa do Estado do Rio de Janeiro
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES)

Zitieren

APA

Nadur, N. F., Ferreira, L. A. P., Franco, D. P., de Azevedo, L. L., Caruso, L., Honório, T. D. S., Furtado, P. S., Simon, A., Cabral, L. M., Werner, T., Stark, H., & Kümmerle, A. E. (2025). Design, Synthesis, and Biological Evaluation of Novel Multitarget 7-Alcoxyamino-3-(1,2,3-triazole)-coumarins as Potent Acetylcholinesterase Inhibitors. Pharmaceuticals, 18(9), 1398. https://doi.org/10.3390/ph18091398

Vancouver

Nadur NF, Ferreira LAP, Franco DP, de Azevedo LL, Caruso L, Honório TDS, et al. Design, Synthesis, and Biological Evaluation of Novel Multitarget 7-Alcoxyamino-3-(1,2,3-triazole)-coumarins as Potent Acetylcholinesterase Inhibitors. Pharmaceuticals. 2025;18(9):1398. doi:10.3390/ph18091398

BibTeX
@article{Nadur2025,
  author = {Nadur, Nathalia F and Ferreira, Larissa de A P and Franco, Daiana P and de Azevedo, Luciana L and Caruso, Lucas and Honório, Thiago da S and Furtado, Priscila de S and Simon, Alice and Cabral, Lucio M and Werner, Tobias and Stark, Holger and Kümmerle, Arthur E},
  title = {Design, Synthesis, and Biological Evaluation of Novel Multitarget 7-Alcoxyamino-3-(1,2,3-triazole)-coumarins as Potent Acetylcholinesterase Inhibitors},
  journal = {Pharmaceuticals},
  year = {2025},
  volume = {18},
  number = {9},
  pages = {1398},
  doi = {10.3390/ph18091398}
}
Kostenlos starten →